BTMD: biote Corp. - Summary | Jitta

biote Corp.

NASDAQ:BTMD

Price
$1.99
Loss Chance
46.1%
3.51JITTA SCORE
52.23%Under Jitta Line
Jitta Ranking
422 / 715
3,089 / 4,217
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (34)
Recent Business Performance (11)
Financial Strength (68)
Return to Shareholders (13)
Competitive Advantage (28)
Jitta Signs
CapExVery Low
Revenue and EarningRevenue decline from 2022-2025
Operating MarginInconsistent
Recent Business PerformanceEarning decline 48.61% in the last quarter (yoy)
New Share IssuedMore than 50% in 5 years
Key Stats
Jitta Score
Jitta Line
3.51
52.23%
3.06
96.59%
3.06
206.98%
Pharmaceuticals
4.95
53.41%
5.05
79.98%
5.69
90.19%
COMPANY DESCRIPTION
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other administrative requirements; inventory management software to facilitate ordering and inventory control; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female patients. The company was founded in 2012 and is headquartered in Irving, Texas.